THE LANDMARK TRIAL PENN STATE, 6 MONTHS, PEER-REVIEWED: A 6-month randomized, double-blind, placebo-controlled human trial of 54 adults at Penn State University (Richie et al., European Journal of Nutrition, 2015) found that oral Setria L-Glutathione at 250 mg/day produced significant increases in whole-blood glutathione levels at 1, 3, and 6 months versus baseline establishing for the first time that oral glutathione is bioavailable in humans
The therapeutic window for inhibiting GGT as a cancer therapy is potentially large, as sustained inhibition of GGT activity did not induce any overt toxicities
Sadly, I didn't end up using them all, but was very careful to store the remainder in a dark, cool spot (which certainly never exceeded 25 degrees Celsius), and the ampoules themselves have never been taken out of their boxes for any reason, so exposure to light won't have been an issue
Thus the primary effect of the inhibition is to prevent excess accumulation of GSH